An integrated pan‐cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity-Reference-Cited by-同舟云学术

An integrated pan‐cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity

Author:

Liu Jian‐Nan¹,Kong Xiang‐Shuo¹,Sun Ping¹^ORCID,Wang Rui²,Li Wang³^ORCID,Chen Qi‐Feng³⁴⁵^ORCID

Affiliation:

1. Department of Oncology Yantai Yuhuangding Hospital Yantai China

2. Department of Respiratory Oncology Fushan district people's hospital Yantai China

3. Department of Medical Imaging and Interventional Radiology Sun Yat‐sen University Cancer Center Guangzhou China

4. State Key Laboratory of Oncology in South China Guangzhou China

5. Collaborative Innovation Center for Cancer Medicine Guangzhou China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

Reference41 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA,2018

3. Profiles of m(6)A RNA methylation regulators for the prognosis of hepatocellular carcinoma;Li W;Oncology Letters,2020

5. Pharmacogenomic agreement between two cancer cell line data sets;Cancer Cell Line Encyclopedia C, Genomics of Drug Sensitivity in Cancer C;Nature,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献